5-Layer StackThe Clav Protocol
−28.7%Retatrutide Phase 2
11 TotalStack Compounds
>98%HPLC Purity
$200+Free Shipping
The Clav Stack · Clavicular's Protocol · 2026

The Official
Clav Protocol.
Every Compound.
All The Data.

Clavicular's complete 5-layer peptide stack — Retatrutide triple-agonist for −28.7% body fat, BPC-157 gut protection, GHK-CU GLOW, SNAP-8 KLOW, and CJC-1295/Ipamorelin lean mass. Every compound documented. Research-grade sourcing.

−28.7%
Body weight · Retatrutide Phase 2
5
Protocol layers · Fat · Gut · GLOW · KLOW · Mass
48wk
Phase 2 duration · Weight loss not plateaued
$405
Full stack cost · All 5 layers
The Protocol
Full breakdown →
01
Triple-AgonistGLP-1 · GIP · Glucagon

GLP-3 R — Retatrutide

The engine of the stack. Hits all three receptors — the glucagon agonism is what separates it from tirzepatide. Phase 2 showed −28.7% at 48 weeks. The fat loss core.

02
Gut ProtectionNO-system · gastric mucosal

BPC-157 — Gut Guardrail

GLP-1 agonists hit the gut hard. BPC-157 keeps it intact. 36+ preclinical studies, no minimum toxic dose found. The guardrail on an aggressive Retatrutide protocol.

03
GLOWcollagen · copper peptide · 4,000+ genes

GHK-CU — The GLOW Peptide

Upregulates 4,000+ skin biology genes. Collagen synthesis, VEGF angiogenesis, Cu-SOD antioxidant defense. When you lose 28% body weight, GHK-CU makes the skin show it well.

04
KLOWSNAP-25 NMJ analog · expression wrinkles

SNAP-8 — The KLOW Peptide

SNAP-25 N-terminal analog. Partially inhibits ACh at the NMJ — reducing expression muscle contraction force. Preclinical models: up to 63% wrinkle depth reduction.

05
Lean Massdual GH secretagogue · GHRH + GHRP

CJC-1295 / Ipamorelin — Lean Mass

Pulsatile GH secretagogue combo. Preserves lean mass during aggressive Retatrutide fat loss. No cortisol elevation. Optional layer for those training hard.

Full Stack · 5 Layers

The Science

Why Not Semaglutide.
Why Not Tirzepatide.
Why Retatrutide.

Semaglutide activates one receptor — GLP-1. It's the pioneer and the benchmark. Tirzepatide adds GIP and gained 5 percentage points. Retatrutide adds a third: glucagon receptor agonism, which directly increases hepatic energy expenditure.

That third receptor is the difference between pharmaceutical-grade weight loss and something that rewrites what your body is capable of losing. Phase 2 data: −28.7% at the high dose, 48 weeks. Retatrutide isn't the next iteration — it's a different category.

Weight Loss Comparison

Semaglutide
GLP-1 · STEP-1
−14.9%
Tirzepatide
GLP-1 + GIP · SURMOUNT-1
−20.9%
RetatrutideClav's Pick
GLP-1 + GIP + GcgR · Phase 2
−28.7%

The Official Protocol. The Only Stack.

Build the Stack.
Run the Protocol.

Every compound in Clavicular's protocol in one place. HPLC verified, research grade, ships from the US.